MedTrace Logo

Randomized Study to Compare the Bioavailability of Three Mometasone Furoate 0.1% Topical Lotions

NCT00805155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2021-10-15

No results posted yet for this study

Summary

The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Mometasone Furoate 0.1% Topical Lotions in healthy, female subjects.

Conditions

  • Healthy

Interventions

DRUG

Mometasone Furoate 0.1% Topical Lotion-Reference Product

Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response.

DRUG

Mometasone Furoate 0.1% Topical Lotion-Test product 1

Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response.

DRUG

Mometasone Furoate 0.1% Topical Lotion-Test Product 2

Small amount applied and evaluated over the course of two days. ChromaMeter used to measure response.

Sponsors & Collaborators

  • Padagis LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2004-03-31
Completion
2004-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805155 on ClinicalTrials.gov